Trials
TUSTIN, CA: TUSTIN, CA -- (Marketwire) -- 09/01/11 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment ...
BUFFALO, NY: BUFFALO, NY -- (Marketwire) -- 08/10/11 -- (NASDAQ: CBLI) today announced that Science Translational Medicine, a leading peer-reviewed research magazine dedicated to communication and cross-fertili ...
PARSIPPANY, NJ: Independent Health Standards Organization Recommends Bivalirudin Strategy for STEMI Patients Undergoing Primary PCI ...
MINNEAPOLIS, MN: Clinical Data Published in the Journal of Alzheimer's Disease and Presented at the 2011 ICAD Meeting ...
TUSTIN, CA: Three Phase II Programs Advancing in Oncology and HCV Infection Indications ...